रिकॉर्ड उद्धरण

एपीए उद्धरण

Griffiths, R. I., Gleeson, M. L., Mikhael, J., & Danese, M. D. (2012). Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare. Hindawi Publishing Corporation.

शिकागो स्टाइल उद्धरण

Griffiths, Robert I., Michelle L. Gleeson, Joseph Mikhael, और Mark D. Danese. Impact On Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based On SEER-Medicare. Hindawi Publishing Corporation, 2012.

एमएलए उद्धरण

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.